Re­gen­eron plans to buy 23andMe for $256M

23andMe has found a buy­er.

Re­gen­eron will buy the strug­gling 23andMe through its court-su­per­vised sale for $256 mil­lion, the com­pa­nies dis­closed Mon­day morn­ing.

The move …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA